We are live on ! Find out more
CBAY

Cymabay Therapeutics

Delisted

CBAY was delisted on the 21st of March, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$2.29M
A
2
Abingworth
United Kingdom
$2.16M
VVM
3
Versant Venture Management
California
$1.42M
KCM
4
Kingdon Capital Management
New York
$1.29M -$43.4K -35,000 -4%
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$1.14M -$237K -191,488 -18%
LOAMU
6
Lombard Odier Asset Management (USA)
New York
$958K -$466K -376,241 -35%
OFM
7
Omega Fund Management
Massachusetts
$818K -$54.4K -43,900 -7%
Vanguard Group
8
Vanguard Group
Pennsylvania
$742K +$62.7K +50,627 +10%
JGC
9
J. Goldman & Co
New York
$323K -$145K -117,000 -33%
AllianceBernstein
10
AllianceBernstein
Tennessee
$317K
Renaissance Technologies
11
Renaissance Technologies
New York
$150K +$62.1K +50,100 +82%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$132K
SM
13
Sabby Management
Florida
$91K -$652K -526,366 -89%
PVI
14
Pura Vida Investments
New York
$76K -$178K -144,000 -72%
BFA
15
BlackRock Fund Advisors
California
$68K -$4.91K -3,964 -7%
BIT
16
BlackRock Institutional Trust
California
$62K
Northern Trust
17
Northern Trust
Illinois
$41K
HF
18
Hoxton Financial
West Virginia
$35K
Parallax Volatility Advisers
19
Parallax Volatility Advisers
California
$34K
Bank of New York Mellon
20
Bank of New York Mellon
New York
$29K -$951 -768 -3%
ACI
21
Alpha Cubed Investments
California
$27K
Citadel Advisors
22
Citadel Advisors
Florida
$15K +$13.6K +10,979 New
TRCT
23
Tower Research Capital (TRC)
New York
$8K +$4.09K +3,304 +134%
BIM
24
BlackRock Investment Management
Delaware
$5K
Bank of America
25
Bank of America
North Carolina
$3K